News
April 23, 2020

Survey to shed light on impact of hospital stays on COVID-19 survivors

Intensive care unit behind closed glass door

Admission to the hospital and critical illness can have a lasting impact on the lives of people who survive, especially those in need of life support. During the COVID-19 pandemic, many people admitted to the intensive care unit (ICU) for the virus are treated with mechanical ventilators and sedatives, which increase the risk of delirium, a type of brain failure, and post-intensive care syndrome. Post intensive care syndrome impairs the recovery of patients for up to two years after hospitalization, causing mental health, physical, quality of life and cognitive problems.

Regenstrief Institute and Indiana University researchers are working to understand how many COVID-19 survivors are dealing with delirium-related distress and post-intensive care syndrome following their recovery. To accomplish this, the team has created a survey to gather information on symptoms that people experienced during their illness and treatment, how they are recovering, and what they are thinking and feeling during their recovery.

The data gathered will provide an understanding of how many survivors are dealing with delirium-related distress and give insight into how they are coping with the stress of being treated in the ICU. Through this information, the study team hopes to understand what COVID-19 survivors need to recover.

The project is being led by Heidi Lindroth, PhD, R.N., a postdoctoral fellow at Regenstrief and Indiana University School of Medicine, and Sikandar Khan, D.O., M.S., a scientist at IU Center for Aging Research at Regenstrief Institute and an assistant professor of medicine at Indiana University School of Medicine. Other members of the team include Babar Khan, M.D., M.S., and Malaz Boustani, M.D., MPH of Regenstrief and IU School of Medicine and Jill Conners, PhD, and Sophia Wang, M.D. of IU School of Medicine.

If you have tested positive for COVID-19, you are invited to fill out this survey.

About Regenstrief Institute

Founded in 1969 in Indianapolis, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its researchers are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform practice and improve the lives of patients around the globe.

Regenstrief Institute is celebrating 50 years of healthcare innovation. Sam Regenstrief, a successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute’s research mission.

Related News

LOINC version 2.81 release

Arabic and Czech translations, more than 4,000 new concepts boost global interoperability in latest LOINC® release

Regenstrief Institute’s latest LOINC® content update on August 12, introduces two new linguistic variants: Arabic, for users in Jordan,

Regenstrief President and CEO Rachel Patzer, PhD, MPH.

Regenstrief CEO among national honorees for ground-breaking achievements in transplantation

SAN FRANCISCO – Regenstrief Institute President and Chief Executive Officer Rachel Patzer, PhD, MPH, is among a select group

LOINC 2025 Conference - Montreal, Canada

Regenstrief to host 2025 LOINC® conference in Montréal, Canada, Oct. 7-10

First LOINC conference in Canada — home to one of LOINC’s largest user bases  Regenstrief Institute Health Data Standards

Katie Ross-Driscoll, PhD

Regenstrief researcher receives Showalter award to improve access to organ transplants using learning health systems approach

Regenstrief Institute Research Scientist Katie Ross-Driscoll, PhD, MPH, has been awarded a 2025 Ralph W. and Grace M. Showalter